Five plaintiffs were awarded a total of $502 million dollars in the 2nd test (bellwether) case to go to trial against Johnson & Johnson (J&J) relating to its Depuy Pinnacle hip implants, in January of 2016,  J&J appealed the verdict, which the trial judge reduced to $151 million dollars.  The 5th Circuit Court of Appeals heard oral argument on December 7, 2017, and issued their opinion  in April 2018. The Fifth Circuit overturned the entire verdict and remanded the case back to the Northern District of Texas and Judge Ed Kinkeade for a new trial.… Read More


A jury in Dallas federal court ordered Johnson & Johnson’s DePuy Orthopaedics unit to pay more than $1 billion dollars to six Pinnacle hip recipients who suffered serious medical complications from their DePuy Pinnacle hip implants. The jury found that the metal-on-metal Pinnacle hips were defectively designed, and that J&J and DePuy failed to warn patients and doctors about the risks.… Read More


Today there are multiple news reports of great interest to people suffering from defective hip replacements: Johnson & Johnson’s subsidiary DePuy Orthopaedics has agreed to a tentative settlement of over 4 billion dollars to resolve thousands of DePuy Articular Surface Replacement (ASR) hip implant lawsuits. This would make it the largest recorded settlement for a defective medical device in US history.… Read More


A second DePuy ASR hip implant case scheduled for trial this month has been resolved, according to court records. The lawsuit, MacDonald et al v. DePuy Orthopaedics Inc. et al, was filed in the Bergen County division of the New Jersey Superior Court and was scheduled to go to trial on October 21, 2013 before the Honorable Brian R. Martinotti. There are few details about the settlement available at this time and, as with prior Depuy hip settlements, the terms will likely remain confidential.

The lawsuit, MacDonald et al v. DePuy Orthopaedics Inc. et al, was filed in the Bergen County division of the New Jersey Superior Court and was scheduled to go to trial on October 21, 2013 before the Honorable Brian R. Martinotti. There are few details about the settlement available at this time and, as with prior Depuy hip settlements, the terms will likely remain confidential.… Read More


Johnson & Johnson subsidiary DePuy Orthopaedics has agreed to settle a DePuy ASR hip lawsuit before trial. The case would have been the first “bellwether” trial in a California state court consolidation of ASR cases. The Plaintiff, Mr. Robert Eugene Ottman, was set to begin presenting his case in two weeks in state court in San Francisco. … Read More


DePuy Orthopaedics, Inc., recalled the DePuy ASR™ XL Acetabular Hip System on August 24, 2010, three years ago this coming Saturday. The three-year statute of limitations applicable to Massachusetts claims (and claims in states with a similar limitations period) could possibly expire in many cases at the end of this month. DePuy Orthopaedics, a division of Johnson & Johnson, recalled its ASR Hip System because of an exceptionally high failure rate and resulting metal poisoning. DePuy’s Pinnacle® metal-on-metal hip system, which remains on the market today but is being phased out by J&J, is experiencing similar failures.… Read More


The FDA and DePuy have issued a class-1 recall, the highest alert, of DePuy’s femur and tibia implant called the LPS Lower Extremity Dovetail Intercalary Component. This is because this device has the potential to fracture when the patient walks normally or conducts normal activities – like ascending stairs, or rising from a chair. People weighing over 200 pounds or with high activity levels are at higher risk of fractures.… Read More